cbdMD
YCBD
24 hedge funds and large institutions have $227K invested in cbdMD in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
51% more capital invested
Capital invested by funds: $150K → $227K (+$76.6K)
20% more funds holding
Funds holding: 20 → 24 (+4)
0.29% more ownership
Funds ownership: 0.63% → 0.92% (+0.29%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AXS Investments
Port Chester,
New York
|
+$21.2K |
| 2 |
VF
Virtu Financial
New York
|
+$18.4K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13.5K |
| 4 |
Renaissance Technologies
New York
|
+$3.46K |
| 5 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$2.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.22K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$105 |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
UBS Group
Zurich,
Switzerland
| – | -$105 | -13 | Closed |
|
|
27
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$1 | – | – |
|
YCBD Hedge Fund Activity: Q4 2023 in Review
24 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q4 2023, worth a combined $227K — up 51% from $150K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new YCBD positions and 1 closed out — a net gain of 4 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was AXS Investments, adding an estimated $21.2K. The largest seller was Royal Bank of Canada, cutting an estimated $2.22K.
- 24 institutional investors held cbdMD (YCBD) as of Q4 2023, up from 20 in Q3 2023.
- Funds reported $227K of cbdMD stock for Q4 2023, up 51% quarter-over-quarter.
- 5 funds opened new cbdMD positions in Q4 2023 and 1 closed out, a net change of +4 holders.
- The largest cbdMD buyer in Q4 2023 was AXS Investments, an estimated $21.2K added.
- The largest cbdMD seller in Q4 2023 was Royal Bank of Canada, an estimated $2.22K sold.
Based on aggregated 13F filings for Q4 2023.